These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38625013)

  • 21. [Escherichia coli productora de betalactamasas de espectro extendido como agente causal de gangrena de Fournier de origen urogenital asociada a mayor mortalidad].
    Carrillo-Córdova LD; Aguilar-Aizcorbe S; Hernández-Farías MA; Acevedo-García C; Soria-Fernández G; Garduño-Arteaga ML
    Cir Cir; 2018; 86(4):327-331. PubMed ID: 30067712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mortality associated with Fournier's gangrene remains unchanged over 25 years.
    Radcliffe RS; Khan MA
    BJU Int; 2020 Apr; 125(4):610-616. PubMed ID: 31975540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fournier's gangrene: is it scrotal gangrene?
    Cakmak A; Genç V; Akyol C; Kayaoğlu HA; Hazinedaroğlu SM
    Adv Ther; 2008 Oct; 25(10):1065-74. PubMed ID: 18821069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [FOURNIER GANGRENE: AN ANALYSIS OF 15 CASES].
    Sakamoto A; Kaneko T; Kanatani A; Kimura M; Takahashi S; Yamada Y; Miyake Y; Sakamoto T; Nakagawa T
    Nihon Hinyokika Gakkai Zasshi; 2021; 112(2):65-69. PubMed ID: 35444083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Fournier's gangrene: an eleven year retrospective analysis of early recognition, diagnosis, and treatment.
    Norton KS; Johnson LW; Perry T; Perry KH; Sehon JK; Zibari GB
    Am Surg; 2002 Aug; 68(8):709-13. PubMed ID: 12206606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of different scoring systems for predicting in-hospital mortality for patients with Fournier gangrene.
    Azmi YA; Alkaff FF; Renaldo J; Wirjopranoto S; Prasetiyanti R; Soetanto KM; Salamah S; Purba AKR; Postma MJ
    World J Urol; 2023 Oct; 41(10):2751-2757. PubMed ID: 37580468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New insights into the epidemiology and etiology of Fournier's gangrene: a review of 33 patients.
    Czymek R; Hildebrand P; Kleemann M; Roblick U; Hoffmann M; Jungbluth T; Bürk C; Bruch HP; Kujath P
    Infection; 2009 Aug; 37(4):306-12. PubMed ID: 19629386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting mortality in Fournier's gangrene: experience with fifty-two patients.
    Ersoz F; Sari S; Arikan S; Altiok M; Bektas H; Adas G; Poyraz B; Ozcan O
    Singapore Med J; 2012 Aug; 53(8):537-40. PubMed ID: 22941132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fournier's gangrene: risk factors and strategies for management.
    Yanar H; Taviloglu K; Ertekin C; Guloglu R; Zorba U; Cabioglu N; Baspinar I
    World J Surg; 2006 Sep; 30(9):1750-4. PubMed ID: 16927060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbiological aspects of Fournier's gangrene.
    Yilmazlar T; Gulcu B; Isik O; Ozturk E
    Int J Surg; 2017 Apr; 40():135-138. PubMed ID: 28257985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fournier's gangrene. Current perspectives].
    Urdaneta Carruyo E; Méndez Parra A; Urdaneta Contreras AV
    An Med Interna; 2007 Apr; 24(4):190-4. PubMed ID: 17867905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fournier's gangrene: not as lethal as previously thought? A case series.
    Heijkoop B; Parker N; Spernat D
    ANZ J Surg; 2019 Apr; 89(4):350-352. PubMed ID: 30173412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenging Treatment of a Female Patient with Extensive Fournier's Gangrene - Case Report.
    Kostovski O; Spasovska O; Trajkovski G; Antovic S; Kostovska I; Tosheska-Trajkovska K; Kuzmanovska B; Pejkova S; Jankulovski N
    Prague Med Rep; 2021; 122(1):39-44. PubMed ID: 33646941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analyzing Outcomes Among Older Adults With Necrotizing Soft-Tissue Infections in the United States.
    McCarty AR; Villarreal ME; Tamer R; Strassels SA; Schubauer KM; Paredes AZ; Santry H; Wisler JR
    J Surg Res; 2021 Jan; 257():107-117. PubMed ID: 32818779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fournier's gangrene mortality: A 17-year systematic review and meta-analysis.
    El-Qushayri AE; Khalaf KM; Dahy A; Mahmoud AR; Benmelouka AY; Ghozy S; Mahmoud MU; Bin-Jumah M; Alkahtani S; Abdel-Daim MM
    Int J Infect Dis; 2020 Mar; 92():218-225. PubMed ID: 31962181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fournier's gangrene: etiology and outcome analysis of 41 patients.
    Altarac S; Katušin D; Crnica S; Papeš D; Rajković Z; Arslani N
    Urol Int; 2012; 88(3):289-93. PubMed ID: 22433163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fournier's gangrene: prospective study of 34 patients in South Indian population and treatment strategies.
    Sockkalingam VS; Subburayan E; Velu E; Rajashekar ST; Swamy AM
    Pan Afr Med J; 2018; 31():. PubMed ID: 31037161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic factors in Fournier gangrene.
    Jeong HJ; Park SC; Seo IY; Rim JS
    Int J Urol; 2005 Dec; 12(12):1041-4. PubMed ID: 16409607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience in management of Fournier's gangrene: a report of 24 cases.
    Wang L; Han X; Liu M; Ma Y; Li B; Pan F; Li W; Wang L; Yang X; Chen Z; Zeng F
    J Huazhong Univ Sci Technolog Med Sci; 2012 Oct; 32(5):719-723. PubMed ID: 23073803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.